Discovery of next generation A3 adenosine receptor selective agonists for treatment of chronic neuropathic pain

被引：0
|
作者：
Tosh, Dilip K. [1 ]
Paoletta, Silvia [1 ]
Ford, Amanda [2 ]
Janes, Kali [2 ]
Salvemini, Daniela [2 ]
Jacobson, Kenneth A. [1 ]
机构：
[1] NIDDKD, Mol Recognit Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA
[2] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2014年 / 247卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
71-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Efficient, large-scale synthesis and preclinical studies of MRS5698, a highly selective A3 adenosine receptor agonist that protects against chronic neuropathic pain
    Dilip K. Tosh
    Janak Padia
    Daniela Salvemini
    Kenneth A. Jacobson
    Purinergic Signalling, 2015, 11 : 371 - 387
  • [32] 2-pyrazolyl-N6-substituted adenosine derivatives as potent and selective A3 adenosine receptor agonists.
    Elzein, E
    Palle, V
    Wu, YZ
    Maa, T
    Zeng, DW
    Zablocki, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U53 - U53
  • [33] Targeting A3 adenosine receptor in HIV-1 gp120-induced neuropathic pain
    Zhang, H.
    Doyle, T.
    Grenald, S.
    Jacobson, K.
    Salvemini, D.
    Vanderah, T.
    JOURNAL OF PAIN, 2017, 18 (04): : S24 - S24
  • [34] 2-pyrazolyl-N6-substituted adenosine derivatives as high affinity and selective adenosine A3 receptor agonists
    Elzein, E
    Palle, V
    Wu, YZ
    Maa, TN
    Zeng, DW
    Zablocki, J
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (19) : 4766 - 4773
  • [35] Adenosine A3 agonists reverse neuropathic pain via T cell-mediated production of IL-10
    Durante, Mariaconcetta
    Squillace, Silvia
    Lauro, Filomena
    Giancotti, Luigino Antonio
    Coppi, Elisabetta
    Cherchi, Federica
    Mannelli, Lorenzo Di Cesare
    Ghelardini, Carla
    Kolar, Grant
    Wahlman, Carrie
    Opejin, Adeleye
    Xiao, Cuiying
    Reitman, Marc L.
    Tosh, Dilip K.
    Hawiger, Daniel
    Jacobson, Kenneth A.
    Salvemini, Daniela
    JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (07):
  • [36] QUANTITATIVE STRUCTURE-ACTIVITY STUDIES OF SELECTIVE A3 ADENOSINE AGONISTS
    SIDDIQI, SM
    PEARLSTEIN, RA
    SANDERS, LH
    JACOBSON, KA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 204 - MEDI
  • [37] Conversion of A3 adenosine receptor agonists into selective antagonists by modification of the 5′-ribofuran-uronamide moiety
    Gao, ZG
    Joshi, BV
    Klutz, AM
    Kim, SK
    Lee, HW
    Kim, HO
    Jeong, LS
    Jacobson, KA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (03) : 596 - 601
  • [38] Interaction of SSR161421, a novel specific adenosine A3 receptor antagonist with adenosine A3 receptor agonists both in vitro and in vivo
    Mikus, Endre G.
    Boer, Kinga
    Timari, Geza
    Urban-Szabo, Katalin
    Kapui, Zoltan
    Szeredi, Judit
    Gerber, Katalin
    Szabo, Tibor
    Batori, Sandor
    Finet, Michel
    Aranyi, Peter
    Galzin, Anne-Marie
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 699 (1-3) : 62 - 66
  • [39] N6-Ethyl-2-alkynyl NECAs, selective human A3 adenosine receptor agonists
    Zhu, R
    Frazier, CR
    Linden, J
    Macdonald, TL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (09) : 2416 - 2418
  • [40] Synthesis of hypermodified adenosine derivatives as selective adenosine A3 receptor ligands
    Cosyn, L
    Gao, ZG
    Van Rompaey, P
    Lu, CR
    Jacobson, KA
    Van Calenbergh, S
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (05) : 1403 - 1412
12345